Sionna Therapeutics, Inc. financial data

Symbol
SION on Nasdaq
Location
21 Hickory Drive, Suite 500, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.1M shares
Common Stock, Shares, Outstanding 44.1M shares
Common Stock, Value, Issued 44K USD
Weighted Average Number of Shares Outstanding, Basic 44.1M shares +1296%
Weighted Average Number of Shares Outstanding, Diluted 44.1M shares +1296%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.4M USD +86.8%
General and Administrative Expense 6.52M USD +113%
Operating Income (Loss) -21.9M USD -94%
Nonoperating Income (Expense) 3.84M USD +40.1%
Net Income (Loss) Attributable to Parent -18.1M USD -111%
Earnings Per Share, Basic -410 USD/shares +84.9%
Earnings Per Share, Diluted -410 USD/shares +84.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 41M USD -6.9%
Cash, Cash Equivalents, and Short-term Investments 337M USD
Assets, Current 267M USD
Property, Plant and Equipment, Net 2.25M USD
Operating Lease, Right-of-Use Asset 7.4M USD
Other Assets, Noncurrent 0 USD
Assets 352M USD
Employee-related Liabilities, Current 1.99M USD
Accrued Liabilities, Current 5.47M USD
Liabilities, Current 7.55M USD
Operating Lease, Liability, Noncurrent 8.07M USD
Liabilities 15.6M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 183K USD
Retained Earnings (Accumulated Deficit) -216M USD
Stockholders' Equity Attributable to Parent 336M USD
Liabilities and Equity 352M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -23.6%
Net Cash Provided by (Used in) Financing Activities 202M USD +11.6%
Net Cash Provided by (Used in) Investing Activities -141M USD -13.9%
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 44.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 44.9M USD +1.53%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.9M USD -6.76%
Depreciation 100K USD -50%
Payments to Acquire Property, Plant, and Equipment 86K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.2M USD -109%
Property, Plant and Equipment, Gross 4.12M USD
Operating Lease, Liability, Current 1.17M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 552M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.84M USD +192%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares